Review
doi: 10.1016/j.febslet.2006.10.061.
Epub 2006 Nov 3.
IL-1 receptor antagonist in metabolic diseases: Dr Jekyll or Mr Hyde?
Affiliations
- PMID: 17097645
- DOI: 10.1016/j.febslet.2006.10.061
Item in Clipboard
Review
IL-1 receptor antagonist in metabolic diseases: Dr Jekyll or Mr Hyde?
FEBS Lett.
.
Free article
Abstract
Interleukin-1 receptor antagonist (IL-1ra) has been shown to play a crucial role in the prevention of various inflammatory diseases. There is also convincing evidence that IL-1ra is able to counteract inflammatory effects of IL-1 members implicated in insulin resistance and diabetes. However, the use of knock-out animal models provides evidence to the contrary and the role of IL-1ra in obesity-linked anomalies remains controversial. This minireview gets an insight into recent findings on the implication of IL-1ra and its gene polymorphism in diabetes and obesity, discusses the potential dual effects of IL-1ra observed in different models, and comments on future directions.
Similar articles
-
Interleukin-1 receptor antagonist (IL-1Ra) and IL-1Ra producing mesenchymal stem cells as modulators of diabetogenesis.Autoimmunity. 2010 Jun;43(4):255-63. doi: 10.3109/08916930903305641. Autoimmunity. 2010. PMID: 19845478 Review.
-
In vivo mucosal delivery of bioactive human interleukin 1 receptor antagonist produced by Streptococcus gordonii.BMC Biotechnol. 2003 Sep 17;3:15. doi: 10.1186/1472-6750-3-15. Epub 2003 Sep 17. BMC Biotechnol. 2003. PMID: 13129437 Free PMC article.
-
Age-dependent regulation of depression-like behaviors through modulation of adrenergic receptor α₁A subtype expression revealed by the analysis of interleukin-1 receptor antagonist knockout mice.Neuroscience. 2011 Sep 29;192:475-84. doi: 10.1016/j.neuroscience.2011.06.031. Epub 2011 Jun 17. Neuroscience. 2011. PMID: 21722710
-
Is IL-1 a good therapeutic target in the treatment of arthritis?Best Pract Res Clin Rheumatol. 2006 Oct;20(5):879-96. doi: 10.1016/j.berh.2006.06.004. Best Pract Res Clin Rheumatol. 2006. PMID: 16980212 Review.
-
IL-1/IL-1ra balance in the brain revisited - evidence from transgenic mouse models.Brain Behav Immun. 2009 Jul;23(5):573-9. doi: 10.1016/j.bbi.2009.02.015. Epub 2009 Mar 1. Brain Behav Immun. 2009. PMID: 19258032 Review.
Cited by
-
Energy-sensing factors coactivator peroxisome proliferator-activated receptor γ coactivator 1-α (PGC-1α) and AMP-activated protein kinase control expression of inflammatory mediators in liver: induction of interleukin 1 receptor antagonist.J Biol Chem. 2012 Jan 13;287(3):1847-60. doi: 10.1074/jbc.M111.302356. Epub 2011 Nov 23. J Biol Chem. 2012. PMID: 22117073 Free PMC article.
-
A novel bifunctional protein TNFR2-Fc-IL-1ra (TFI): expression, purification and its neutralization activity of inflammatory factors.Mol Biotechnol. 2013 Jun;54(2):141-7. doi: 10.1007/s12033-012-9550-7. Mol Biotechnol. 2013. PMID: 22565853
-
Expression-based Genome-wide Association Study Links OPN and IL1-RA With Newly Diagnosed Type 1 Diabetes in Children.J Clin Endocrinol Metab. 2022 Jun 16;107(7):1825-1832. doi: 10.1210/clinem/dgac256. J Clin Endocrinol Metab. 2022. PMID: 35460250 Free PMC article.
-
Lack of formyl peptide receptor 1 and 2 leads to more severe inflammation and higher mortality in mice with of pneumococcal meningitis.Immunology. 2014 Nov;143(3):447-61. doi: 10.1111/imm.12324. Immunology. 2014. PMID: 24863484 Free PMC article.
-
Diabetes treatment--bridging the divide.N Engl J Med. 2007 Apr 12;356(15):1499-501. doi: 10.1056/NEJMp078030. N Engl J Med. 2007. PMID: 17429082 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
